Filing Flows › GoodRx Holdings (GDRX) › Prescription transactions revenue revenue
GoodRx Holdings (GDRX) Prescription transactions revenue revenue by quarter
GoodRx Holdings' Prescription transactions revenue revenue was $106M in Q2 2026 (second quarter 2026), -6% from Q1 2026. Over the last 6 quarters it ranged from $106M (Q2 2026) to $149M (Q1 2025).
| Quarter | Prescription transactions revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $106M | -6% | -26% |
| Q1 2026 | $114M | -11% | -24% |
| Q3 2025 | $127M | -11% | — |
| Q2 2025 | $143M | -4% | — |
| Q1 2025 | $149M | +3% | — |
| Q4 2024 | $145M | — | — |
Q2 2026 at a glance
GoodRx Holdings, Q2 2026: revenue $200M (-1% year over year), operating margin 11.8%, net earnings $8.5M, operating cash flow $80.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is GoodRx Holdings' Prescription transactions revenue revenue?
GoodRx Holdings' Prescription transactions revenue revenue was $106M in Q2 2026 (second quarter 2026), -6% from Q1 2026.
How has GoodRx Holdings' Prescription transactions revenue revenue changed?
Over the last 6 quarters it ranged from $106M (Q2 2026) to $149M (Q1 2025).